AN EFFECTIVE ORAL COMBINATION IN ADVANCED RELAPSED HODGKINS-DISEASE PREDNISOLONE, ETOPOSIDE, CHLORAMBUCIL AND CCNU

被引:19
|
作者
LENNARD, AL
CAREY, PJ
JACKSON, GH
PROCTOR, SJ
机构
[1] Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, Queen Victoria Road
关键词
D O I
10.1007/BF02897235
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many patients with advanced Hodgkin's disease continue to need palliative therapy, but where there is no curative intent, patients and doctors may prefer oral treatment only. This paper describes the preliminary experience of such a schedule. A total of 15 patients with advanced relapsed Hodgkin's disease were treated with an oral regimen, PECC (prednisolone at 40 mg daily for 7 days, etoposide at 200 mg/m2 on days 1 - 3, chlorambucil at 20 mg/m2 on days 1 - 4 and CCNU at 100 mg/m2 on day 1 only), repeated every 4 - 6 weeks. 12 patients had been extensively pretreated. 11 patients had extranodal disease and 8 had B symptoms when treatment was started. Eight patients achieved a complete remission, with a median duration of 7+ months, and five achieved a partial remission; the overall response rate was 86%. Haematological toxicity was the major side effect. There were no treatment-related deaths. All patients tolerated treatment well and the oral route has particular advantages for those unwilling or unable to accept intravenous treatment. © 1990 Springer-Verlag.
引用
收藏
页码:301 / 305
页数:5
相关论文
共 50 条
  • [41] COMBINATION CHEMOTHERAPY INCLUDING BLEOMYCIN IN TREATMENT OF ADVANCED HODGKINS-DISEASE
    BEZWODA, WR
    MACDONALD, DF
    GEAR, JSS
    DERMAN, DP
    BOTHWELL, TH
    ZWI, S
    HURWITZ, S
    LEWIS, D
    SOUTH AFRICAN MEDICAL JOURNAL, 1978, 53 (10): : 369 - 373
  • [42] COMBINATION CHEMOTHERAPY IN HODGKINS-DISEASE
    NORDENTOFT, AM
    JENSEN, KB
    DANISH MEDICAL BULLETIN, 1973, 20 (02) : 52 - 60
  • [43] COMBINATION CHEMOTHERAPY FOR HODGKINS-DISEASE
    NELSON, RB
    ANNALS OF INTERNAL MEDICINE, 1981, 94 (05) : 713 - 713
  • [44] COMBINATION CHEMOTHERAPY FOR HODGKINS-DISEASE
    ROSENFELT, FP
    ANNALS OF INTERNAL MEDICINE, 1985, 102 (04) : 554 - 554
  • [45] COMBINATION THERAPY OF HODGKINS-DISEASE
    NOELL, KT
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 223 (03): : 328 - 328
  • [46] COMBINATION CHEMOTHERAPY IN HODGKINS-DISEASE
    SACKS, PV
    BOTHWELL, TH
    JACOBS, P
    GALE, D
    SOUTH AFRICAN MEDICAL JOURNAL, 1972, 46 (24): : 805 - &
  • [47] HIGH-DOSE ETOPOSIDE AND MELPHALAN WITH NONCRYOPRESERVED MARROW RESCUE IN REFRACTORY AND RELAPSED HODGKINS-DISEASE
    SEYMOUR, L
    DANSEY, R
    BEZWODA, WR
    BLOOD, 1993, 82 (10) : A172 - A172
  • [48] THE SUPERIORITY OF CCNU IN THE TREATMENT OF ADVANCED HODGKINS-DISEASE - CANCER AND LEUKEMIA GROUP-B STUDY
    HANSEN, HH
    SELAWRY, OS
    PAJAK, TF
    SPURR, CL
    FALKSON, G
    BRUNNER, K
    CUTTNER, J
    NISSEN, NI
    HOLLAND, JF
    CANCER, 1981, 47 (01) : 14 - 18
  • [49] MOPP VS MOPP ALTERNATING WITH STREPTOZOTOCIN, CCNU, ADRIAMYCIN AND BLEOMYCIN (SCAB) FOR ADVANCED HODGKINS-DISEASE
    WIERNIK, PH
    LONGO, D
    DUFFEY, PL
    YOUNG, RC
    DEVITA, VT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 159 - 159
  • [50] HODGKINS-DISEASE OF THE ORAL CAVITY
    MEYER, G
    ROSWIT, B
    UNGER, SM
    AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1959, 81 (03): : 430 - 432